Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
Shingles is associated with a statistically significant increase in the risk of myocardial infarction, stroke, and transient ischemic attack.
Study finds higher Ischemic events and mortality in transcatheter valve replacement patients taking non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists.
Low-risk atrial fibrillation patients who take oral anticoagulants have a lower risk of dementia than those who do not, a study says.
The use of direct‐acting oral anticoagulants has increased among nursing home residents with atrial fibrillation.
Overestimating the bleeding risk of anticoagulants may lead to poor compliance.
Two different versions of tafamadis get the FDA’s nod to treat a rare heart disease.
DOACs are as good as warfarin in preventing atrial fibrillation complications.
Three cardiology groups now recommend using NOACs over warfarin in atrial fibrillation.
Black patients with atrial fibrillation are less likely to be treated with oral anticoagulants or DOACs.